The site will be unavailable in 48 minutes for scheduled maintenance.

$71.74 -0.26 (-0.36%)
2/10/2012 4:00 PM

Celgene Corp (NASDAQ:CELG)

CAPS Rating: 4 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Featured Broker Partners


Advertisement